Labcorp price target raised to $310 from $290 at Truist

Truist raised the firm’s price target on Labcorp (LH) to $310 from $290 and keeps a Buy rating on the shares. Truist remains bullish on Labcorp following Q2 results that featured beats on the top and bottom lines, solid trends across segments with operating margin expansion and raised FY guidance, the analyst tells investors in a research note. Financial flexibility remains attractive, supporting execution on the pipeline and return of value to shareholders, the firm adds.